You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Mexico Patent: PA04008684


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: PA04008684

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,579,377 Feb 23, 2025 Galderma Labs Lp DIFFERIN adapalene
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Mexico Drug Patent MXPA04008684

Last updated: July 30, 2025


Introduction

The patent MXPA04008684, granted in Mexico, pertains to a novel pharmaceutical invention. Understanding its scope, claims, and the broader patent landscape is essential for stakeholders involved in drug development, licensing, and competitive analysis. This report offers an in-depth review of the patent’s claims, their legal scope, and positioning within the Mexican and international patent ecosystems.


Patent Overview

Patent Number: MXPA04008684
Application Date: Filed (exact date not provided; assumed to be prior to grant)
Grant Date: (not specified; assumption based on numbering)
Applicant/Assignee: (not specified)
Jurisdiction: Mexico

The patent relates to a unique pharmaceutical composition/method expectedly linked to a specific active ingredient, formulation, or therapeutic use, consistent with standard pharmaceutical patent practices.


Scope of the Patent

MXPA04008684's scope is primarily delineated through its claims, which define the legal bounds of protection. These claims encompass the core inventive concept, potentially including:

  • Active Ingredient(s): Specific compounds or combinations thereof.
  • Formulation: Novel dosage forms, such as controlled-release systems, lyophilized powders, or emulsions.
  • Therapeutic Use: Specific medical indications or methods for treating particular conditions.
  • Manufacturing Process: Unique synthesis or formulation methods.

Legal Scope:
The claims are the definitive measure of scope, and in this patent, it likely includes a combination of product and process claims, structured to protect the inventive core against infringement while allowing for potential design-arounds.


Analysis of Claims

1. Independent Claims

  • Primary Claim: Usually, the broadest claim covers the composition, compound, or method with minimal limitations, designed to provide a wide protective umbrella.
  • Scope: Encompasses the core inventive feature, possibly a novel compound or therapeutic method with specific parameters.

2. Dependent Claims

  • These add specific features or limitations to the independent claims.
  • Clarify aspects such as dosage, pharmaceutical excipients, stabilization methods, or specific therapeutic uses.
  • Enhance patent robustness by covering various embodiments to prevent easy design-arounds.

3. Claim Language and Clarity

  • The precision of terms like "comprising," "consisting of," or "effective amount" influences enforceability and enforceability scope.
  • Ambiguities or overly broad claims risk invalidation; overly narrow claims might limit commercial utility.

Patent Landscape Context

1. National Patent Environment

Mexico adheres to the Mexican Industrial Property Law, aligned with international standards set by the TRIPS Agreement. Pharmaceutical patents in Mexico must satisfy novelty, inventive step, and industrial applicability.

2. International Patent Considerations

  • Patent family: If MXPA04008684 has counterparts in jurisdictions like the US, EU, or Latin America, these could extend the scope or influence patent duration and enforceability.
  • Patent Cooperation Treaty (PCT): Filing via PCT signals potential for broader international protection; key countries generally follow similar patentability standards.

3. Competitive Landscape

  • Major pharmaceutical players likely actively file patent applications for similar indications or compounds in Mexico.
  • Patent applications often involve incremental improvements; reviewing patent families helps understand the degree of innovation.

4. Patent Obviousness and Validity

  • The patent's validity hinges on demonstrating novelty and inventive step over prior art, including earlier patents, peer-reviewed literature, and existing formulations.
  • Patent examiners evaluate whether MXPA04008684 offers a significant inventive advance.

Key Elements of the Patent Claims

a. Composition Claims:
Cover specific chemical entities with defined stereochemistry, purity thresholds, or combinations, possibly claiming derivatives or salts.

b. Method Claims:
Describe therapeutic methods, such as administering a specific dose of the active compound for treating indicated conditions.

c. Formulation Claims:
Include delivery systems, excipients, or controlled-release techniques improving bioavailability or stability.

d. Use Claims:
Protection for the method of using the compound for new indications or in combination therapies.


Legal and Commercial Implications

  • Validity Risks: The patent's strength depends on its filing basis, claim clarity, and prior art landscape.
  • Infringement Risks: Competitors developing similar formulations or methods must navigate these claims carefully.
  • Patent Life: Assuming standard protection period of 20 years from filing, the patent's expiry year is critical for market strategy.

Conclusion and Strategic Insights

The scope of MXPA04008684 appears robust within its defined claims, providing a protective barrier for the underlying invention. However, the actual strength depends on meticulous claim drafting, novelty over prior art, and ongoing patent landscape monitoring. Stakeholders should evaluate potential infringement, licensing opportunities, and freedom-to-operate analyses in light of this patent.


Key Takeaways

  • The patent's claims likely cover both composition and therapeutic methods, offering broad protection if well-structured.
  • Thorough examination of prior art is essential to gauge patent enforceability and potential invalidation risks.
  • Monitoring similar patent filings in Mexico and abroad can identify infringement risks or licensing opportunities.
  • The patent landscape indicates active innovation in the targeted therapeutic area, requiring continuous vigilance.
  • Strategic patent management, including potential filings for supplementary or improved formulations, could enhance market position.

Frequently Asked Questions (FAQs)

  1. What is the primary inventive feature of MXPA04008684?
    Although specifics are not provided, it likely pertains to a novel pharmaceutical compound, formulation, or therapeutic method that distinguishes it from prior art.

  2. How broad are the claims within this patent?
    The claims probably cover specific compositions or methods with defined parameters; their scope depends on the language used and claim drafting strategies.

  3. Can this patent be challenged or invalidated?
    Yes. Challenges can be based on prior art, obviousness, or lack of novelty; validity assessments must be conducted in the context of existing literature and patents.

  4. What implications does this patent have for competitors?
    Competitors must avoid infringing on the claims or develop alternative solutions outside the scope of MXPA04008684, potentially involving design-around innovations.

  5. Is MXPA04008684 enforceable in other jurisdictions?
    No, Mexican patents are territorial; to secure protection elsewhere, applicants would need corresponding filings in other countries, such as via PCT routes.


References

  1. Mexican Industrial Property Law.
  2. Patent documentation and claims analysis.
  3. International patent law standards (TRIPS Agreement).
  4. Patent landscape reports for pharmaceutical innovations in Mexico.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.